302 related articles for article (PubMed ID: 31051046)
1. Hydrogen sulfide and dermatological diseases.
Coavoy-Sánchez SA; Costa SKP; Muscará MN
Br J Pharmacol; 2020 Feb; 177(4):857-865. PubMed ID: 31051046
[TBL] [Abstract][Full Text] [Related]
2. The role of the gasotransmitter hydrogen sulfide in pathological calcification.
Castelblanco M; Nasi S; Pasch A; So A; Busso N
Br J Pharmacol; 2020 Feb; 177(4):778-792. PubMed ID: 31231793
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide and hepatic lipid metabolism - a critical pairing for liver health.
Loiselle JJ; Yang G; Wu L
Br J Pharmacol; 2020 Feb; 177(4):757-768. PubMed ID: 30499137
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system.
Cirino G; Vellecco V; Bucci M
Br J Pharmacol; 2017 Nov; 174(22):4021-4031. PubMed ID: 28407204
[TBL] [Abstract][Full Text] [Related]
5. Signalling by hydrogen sulfide and polysulfides via protein S-sulfuration.
Kimura H
Br J Pharmacol; 2020 Feb; 177(4):720-733. PubMed ID: 30657595
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the functions of myeloid-derived suppressor cells : a new strategy of hydrogen sulfide anti-cancer effects.
De Cicco P; Ercolano G; Rubino V; Terrazzano G; Ruggiero G; Cirino G; Ianaro A
Br J Pharmacol; 2020 Feb; 177(4):884-897. PubMed ID: 31392723
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H
Citi V; Martelli A; Brancaleone V; Brogi S; Gojon G; Montanaro R; Morales G; Testai L; Calderone V
Br J Pharmacol; 2020 Nov; 177(21):4931-4941. PubMed ID: 32783196
[TBL] [Abstract][Full Text] [Related]
8. Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders.
Wang L; Xie X; Ke B; Huang W; Jiang X; He G
J Adv Res; 2022 May; 38():261-274. PubMed ID: 35572410
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide regulates muscle RING finger-1 protein S-sulfhydration at Cys
Sun X; Zhao D; Lu F; Peng S; Yu M; Liu N; Sun Y; Du H; Wang B; Chen J; Dong S; Lu F; Zhang W
Br J Pharmacol; 2020 Feb; 177(4):836-856. PubMed ID: 30734268
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease.
Sikura KÉ; Potor L; Szerafin T; Oros M; Nagy P; Méhes G; Hendrik Z; Zarjou A; Agarwal A; Posta N; Torregrossa R; Whiteman M; Fürtös I; Balla G; Balla J
Br J Pharmacol; 2020 Feb; 177(4):793-809. PubMed ID: 31017307
[TBL] [Abstract][Full Text] [Related]
11. From primordial gas to the medicine cabinet.
Papapetropoulos A; Wallace JL; Wang R
Br J Pharmacol; 2020 Feb; 177(4):715-719. PubMed ID: 31726475
[TBL] [Abstract][Full Text] [Related]
12. Hydrogels for Gasotransmitter Delivery: Nitric Oxide, Carbon Monoxide, and Hydrogen Sulfide.
Sarkar S; Kumar R; Matson JB
Macromol Biosci; 2024 Jan; 24(1):e2300138. PubMed ID: 37326828
[TBL] [Abstract][Full Text] [Related]
13. Erucin exhibits vasorelaxing effects and antihypertensive activity by H
Martelli A; Piragine E; Citi V; Testai L; Pagnotta E; Ugolini L; Lazzeri L; Di Cesare Mannelli L; Manzo OL; Bucci M; Ghelardini C; Breschi MC; Calderone V
Br J Pharmacol; 2020 Feb; 177(4):824-835. PubMed ID: 30825379
[TBL] [Abstract][Full Text] [Related]
14. Effects of sulfide and polysulfides transmitted by direct or signal transduction-mediated activation of TRPA1 channels.
Pozsgai G; Bátai IZ; Pintér E
Br J Pharmacol; 2019 Feb; 176(4):628-645. PubMed ID: 30292176
[TBL] [Abstract][Full Text] [Related]
15. 3-Mercaptopyruvate sulfurtransferase supports endothelial cell angiogenesis and bioenergetics.
Abdollahi Govar A; Törő G; Szaniszlo P; Pavlidou A; Bibli SI; Thanki K; Resto VA; Chao C; Hellmich MR; Szabo C; Papapetropoulos A; Módis K
Br J Pharmacol; 2020 Feb; 177(4):866-883. PubMed ID: 30644090
[TBL] [Abstract][Full Text] [Related]
16. Regulators of the transsulfuration pathway.
Sbodio JI; Snyder SH; Paul BD
Br J Pharmacol; 2019 Feb; 176(4):583-593. PubMed ID: 30007014
[TBL] [Abstract][Full Text] [Related]
17. Chemistry, pharmacology, and cellular uptake mechanisms of thiometallate sulfide donors.
Durham T; Zander D; Stomeo N; Minnion M; Hogarth G; Feelisch M; Singer M; Dyson A
Br J Pharmacol; 2020 Feb; 177(4):745-756. PubMed ID: 30924528
[TBL] [Abstract][Full Text] [Related]
18. A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug.
Wallace JL; Nagy P; Feener TD; Allain T; Ditrói T; Vaughan DJ; Muscara MN; de Nucci G; Buret AG
Br J Pharmacol; 2020 Feb; 177(4):769-777. PubMed ID: 30834513
[TBL] [Abstract][Full Text] [Related]
19. Homeostatic impact of sulfite and hydrogen sulfide on cysteine catabolism.
Kohl JB; Mellis AT; Schwarz G
Br J Pharmacol; 2019 Feb; 176(4):554-570. PubMed ID: 30088670
[TBL] [Abstract][Full Text] [Related]
20. Protein S-sulfhydration by hydrogen sulfide in cardiovascular system.
Meng G; Zhao S; Xie L; Han Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1146-1156. PubMed ID: 28432761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
